MAPT and Alzheimer disease: The expression of DYRK1A increases with age, whereas DYRK1A could promote the formation of characteristic pathological hallmarks of AD by direct phosphorylation of tau and Aβ (Sitz et al., 2008; Chaves et al., 2020).